Microalbuminuria in cerebrovascular diseases

References

• Viberti GC, Jarrett RJ, Mahmud U, Hill RD, Argyropoulos A, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1430–1432 (1982).
   Google Scholar
• Watts GF, Morris RVV, Khan K, Polak A. Urinary albumin excretion in healthy adult subjects: reference values and some factors affecting their interpretation. Clin. Grim. Acta. 172,191–198 (1988).
   PubMedGoogle Scholar
• Haffner SM, Stern MP, Gruber KK, Hazuda HP, Mitchell BD, Patterson JK. Microalbuminuria: potential marker for increased cardiovascular risk factors in nondiabetic subjects? Arteriosclerosis 10, 727–731 (1990).
   Google Scholar
• Jensen JS, Feldt-Rasmussen B, Borch- Johnsen K, Clausen P, Appleyard M, Jensen G. Microalbuminuria and its relation to cardiovascular disease and risk factors. A population-based study of 1254 hypertensive individuals. J. Hum. Hypertens. 11,727-732 (1997).
   Google Scholar
• Jensen JS, Clausen P, Borch-Johnsen K, Jensen G, Feldt-Rasmussen B. Detecting microalbuminuria by urinary albumin/ creatinine concentration ratio. Nephrol Dial. Transplant 12 (suppl. 2), 6–9 (1997).
   Google Scholar
• Gerstein HC, Mann JF, Pogue J et al Prevalence and determinants of microalbuminuria in high-risk diabetic and nondiabetic patients in the Heart Outcomes Prevention Evaluation Study. The HOPE Study Investigators. Diabetes Care 23\(Suppl. 2), B35—B39 (2000).
   Google Scholar
• Pedrinelli R, Dell'Omo G, Di Bello V, Mariani M. Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension. J. Hum. Hypertens. 16,79–89 (2002).
   PubMed Web of Science ®Google Scholar
• •The summary of association between microalbuminuria and hypertension.
   Google Scholar
• Tiu SC, Lee SS, Cheng MW. Comparison of six commercial techniques in the measurement of microalbuminuria in diabetic patients. Diabetes Care 16,616–620 (1993).
   PubMedGoogle Scholar
• Gosling P, Beevers DG. Urinary albumin excretion and blood pressure in the general population. Clin. Sci. 76,39–42 (1989).
   PubMed Web of Science ®Google Scholar
• Montagna G, Buzio C, Calderini C, Quaretti P, Migone L. Relationship of proteinuria and albuminuria to posture and to urine collection period. Nephron 35, 143–144 (1983).
   Google Scholar
• Tetta C, Cavallo-Perin P, Roggero S et al Exercise-induced microalbuminuria in diabetes is associated with urinary excretion of cationic proteins. Clin. Nephrol 30, 270–276 (1988).
   PubMed Web of Science ®Google Scholar
• Purzycki Z, Wyrzykowski B, Gockowski K etal The influence of exercise on albumin excretion rate in borderline hypertensives and in offspring of hypertensive parents. Hum. Hypertens.11, 119–123 (1997).
   Google Scholar
• Gould MM, Mohamed-Ali V, Goubet SA, Yudkin JS, Haines AR Microalbuminuria: associations with height and sex in nondiabetic subjects. Brit. Merl 1. 306, 240–242 (1993).
   Google Scholar
• Horner D, Fliser D, Klimm HP, Ritz E. Albuminuria in normotensive and hypertensive individuals attending offices of general practitioners. I Hypertens.14, 655–660 (1996).
   Google Scholar
• Winocour PH, Harland JOE, Millar JP, Laker ME, Alberti KGMM. Microalbuminuria and associated 220 cardiovascular risk factors in the community. Atherosclerosis 93, 71–81 (1992).
   Google Scholar
• Jensen JS, Feldt-Rasmussen B, Borch-Johnsen K, Jensen G. Urinary albumin excretion in a population based sample of 1011 middle aged nondiabetic subjects. Scand.j Clin. Lab. Invest 53, 867–872 (1993).
   Google Scholar
• Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in nondiabetic subjects. Lancet ii, 530–533 (1988).
   Google Scholar
• Cirillo M, Senigalliesi L, Laurenzi M eta]. Microalbuminuria in nondiabetic adults: relation of blood pressure, body mass index, plasma cholesterol levels and smoking: The Gubbio Population Study. Arch. Intern Merl 158, 1933-1939 (1998).
   Google Scholar
• Gerber LM, Johnston K, Alderman MET. Assessment of a new dipstick test in screening for microalbuminuria in patients with hypertension. Am. j Hypertens.11, 1321–1327 (1998).
   PubMedGoogle Scholar
• Beatty OL, Atkinson AB, Browne J, Clarke K, Sheridan B, Bell PM. Microalbuminuria does not predict cardiovascular disease in a normal general practice population. Ir. Merl Sci.163, 140–142 (1993).
   Google Scholar
• Metcalf P, Baker J, Scragg R, Dryson E, Scott A, Wild C. Microalbuminuria in a middle aged workforce: effect of hyperglycemia and ethnicity. Diabetes Care 16,1485–1493 (1993).
   Google Scholar
• Tomura S, Kawada K, Saito K eta]. Prevalence of microalbuminuria and relationship to the risk of cardiovascular disease in the Japanese population. Am Nephro1.19,13–20 (1999).
   Google Scholar
• Collins VR, Dowse GK, Finch CF, Zimmet PZ, Linnane AW. Prevalence and risk factors for micro and macroalbuminuria in diabetic subjects and entire population of Nauru. Diabetes 38, 1602–1610 (1989).
   Google Scholar
• Haffner SM, Gonzales C, Valdez RA et al Is microalbuminuria part of the prediabetic state? The Mexico City Diabetes Study. Diabetologia. 36, 1002–1006 (1993).
   PubMed Web of Science ®Google Scholar
• Parving HH, Mogensen CE, Jensen HAE, Evrin PE. Increased urinary albumin excretion rate in benign essential hypertension. Lancet i, 1190–1192 (1974).
   Google Scholar
• Bianchi S, Bigazzi S, Campese VM. Microalbuminuria in essential hypertension: significance, pathophysiology and therapeutic implications. Am. j Kidney Dis. 34, 973–995 (1999).
   Google Scholar
• Kofoed-Enevoldsen A, Foyle WJ, Fernandez M, Yudkin JS. Evidence of impaired glomerular charge selectivity in nondiabetic subjects with microalbuminuria. Relevance to cardiovascular disease. Arterioscler. Thmmb. Vasc. Biol. 16, 450–454 (1996).
   Google Scholar
• •Probable mechanism of increased urinary excretion of albumin
   Google Scholar
• Weber MH, Verwiebe R. Alfa-1-microglobulin (protein HC): features of promising indicator of proximal tubular dysfunction. Eur. .1. Chem. Clin. Biochem. 30, 683–691 (1992).
   Google Scholar
• Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM. Hyperfiltration in remnant nephrons: A potential adverse response to renal ablation. Am. j Physiol 241, F85—F93 (1991).
   Google Scholar
• Ruiz-Ortega M, Gomez-Garre D, Alcazar R etal Involvement of angiotensin II and endothelin in matrix protein production and renal sclerosis. j Hypertens. 12 (Suppl. 4), S51—S58 (1994).
   Google Scholar
• Van den Born J, Berden JH. Is microalbuminuria in diabetes due to changes in glomerular heparan sulfate? Nephml. Dial. Transplant10, 1277–1279 (1995).
   Google Scholar
• Makita Z, Radoff S, Rayfield EJ etal Advanced glycosylation end products in patients with diabetic nephropathy. N Engl. Merl 325, 836–841 (1991).
   PubMed Web of Science ®Google Scholar
• Jensen JS, Myrup B, Borch-Johnsen K, Jensen G, Jensen T, Feldt-Rasmussen B. Aspects of haemostatic function in healthy subjects with microalbuminuria, a potential atherosclerotic risk factor. Thromb. Res. 77, 423–430 (1995).
   Google Scholar
• Stehouwer CDA, Fischer HRA, van Kuijk AWR, Polak BCP, Donker AJM. Endothelial dysfunction precedes development of microalbuminuria in IDDM. Diabetes 44, 561–564 (1995).
   PubMed Web of Science ®Google Scholar
• Hirano T, Kashiwazaki K, Moritomo Y, Nagano S, Adachi M. Albuminuria is directly associated with increased plasma PAI-1 and Factor VII levels in NIDDM patients. Diabetes Res. Clin. Pract. 36, 11–18 (1997).
   Google Scholar
• Bazzan M, Gruden G, Stella S etal Microalbuminuria in IDDM is associated with increased expression of monocyte procoagulant activity. Diabetologia 41, 767–771 (1998).
   Google Scholar
• Kario K, Matsu° T, Kobayashi H etal Factor VII hyperactivity and endothelial cell damage are found in elderly hypertensives only when concomitant with microalbuminuria. Arterioscler. Thmmb. Vasc. Biol. 16, 455–461 (1996).
   PubMed Web of Science ®Google Scholar
• Berton G, Cordiano R, Palmieri R, Cucchini F, De Toni R, Palatini Microalbuminuria during acute myocardial infarction. A strong predictor for 1-year mortality. Eur Heart 22, 1466–1475 (2001).
   Google Scholar
• Hoogenberg K, Sluiter WJ, Navis G eta]. Exogenous noradrenaline induces an enhanced microproteinuric response in microalbuminuric insulin-dependent diabetes mellitus. jAm. Soc. Nephrol. 9, 643–654 (1998).
   Google Scholar
• Parving IIf I. Microalbuminuria in essential hypertension and diabetes mellitus. Hypertens. 14\(Suppl. 2), S89—S94 (1996).
   Google Scholar
• Kilaru P, Bakris GL. Microalbuminuria and progressive renal disease. j Hum. Hypertens. 8, 809–817 (1994).
   PubMed Web of Science ®Google Scholar
• Kuusisto J, Mykkanen L, Pyörala K, Laakso M. Hyperinsulinemic microalbuminuria. A new risk indicator for coronary heart disease. Circulation 91, 831–837 (1995).
   Google Scholar
• Mattock MB, Morrish NJ, Viberti G, Keen H, Fitzgerald AP, Jackson G. Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes 41, 736–741 (1992).
   PubMed Web of Science ®Google Scholar
• Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetes. N Engl. j Merl 310, 356–360 (1984).
   PubMed Web of Science ®Google Scholar
• Beilin J, Stanton KG, McCann VJ, Knuiman MW, Divitini ML. Microalbuminuria in Type 2 diabetes: an independent predictor of cardiovascular mortality. Aust. NZJ Merl 26, 519–25 (1996).
   Google Scholar
• Messent JW, Elliot TG, Hill RD, Jarrett RJ, Keen H, Viberti GC. Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a 23 year follow-up study. IOckey Int. 41, 836–839 (1992).
   Google Scholar
• Spoelastra-de Man AM, Brouwer CB, Stehouwer CD, Smulders YM. Rapid progression of albumin excretion is an independent predictor of cardiovascular mortality in patients with Type 2 diabetes and microalbuminuria. Diabetes Cate 24, 2097-2101 (2001).
   Google Scholar
• Bigazzi R, Bianchi S, Baldari D, Campese VM. Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension. Hypertens. 16,1325–1333 (1998).
   Google Scholar
• Cerasola G, Cottone S, Mule G etal Microalbuminuria, renal dysfunction and cardiovascular complications in essential hypertension. Hypertens. 14,915–920 (1996).
   Google Scholar
• Pontremoli R, Sofia A, Ravera M etal. Prevalence and clinical correlates of microalbuminuria in essential hypertension. The MAGIC study. Hypertension 30,1135–1143 (1997).
   Google Scholar
• Bianchi S, Bigazzi R, Baldari G, Sgherri G, Campese VM. Diurnal variations of blood pressure and microalbuminuria in essential hypertension. Am. j Hypertens. 7,23–29 (1994).
   PubMed Web of Science ®Google Scholar
• Hoegholm A, Bang LE, Kristensen KS, Nielsen JW, Holm J. Microalbuminuria in 411 untreated individuals with established hypertension, white coat hypertension and normotension. Hypertension 24,101–105 (1994).
   Google Scholar
• Pontremoli R, Ravera M, Bezante GP et al Left ventricular geometry and function in patients with essential hypertension and microalbuminuria. I Hypertens. 17,993–1000 (1999).
   PubMed Web of Science ®Google Scholar
• Ljungman S, Wikstrand J, Hartford M, Berglund G. Urinary albumin excretion, a predictor of risk of cardiovascular disease. Arn. I Hypertens. 9,770–778 (1996).
   PubMed Web of Science ®Google Scholar
• Vestbo E, Damsgaard EG, Mogensen CE. The relationship between microalbuminuria in first generation diabetic and nondiabetic subjects and microalbuminuria and hypertension in the second generation (a population based study) . Nephrol. Dial. Tiamplant 12 (Suppl. 2), 32–36 (1997).
   Google Scholar
• Woo J, Cockram CS, Swaminathan R, Lau E, Chan A, Cheung R Microalbuminuria and other cardiovascular risk factors in nondiabetic subjects. int. J. Cardid 37, 345–350 (1992).
   PubMed Web of Science ®Google Scholar
• Metcalf P, Baker J, Scott A, Wild C, Scragg R, Dryson E. Albuminuria in a middle-aged population: Effect of obesity, hypertension and hyperlipidemia. Gun. Chem. 39,1802–1808 (1992).
   Google Scholar
• Trevisan R, Walker JD, Viberti GC. Diabetic nephropathy. In: Nephrology Jamison RL, Wilkinson R (Eds). Chapman & Hall, London, UK, 551–574 (1997).
   Google Scholar
• Gosling P, Hughes EA, Reynolds TM, Fox JR Microalbuminuria is an early response following myocardial infarction. Eur Heart J. 12,508–513 (1991).
   PubMed Web of Science ®Google Scholar
• Berton G, Citro T, Palmieri R, Petucco S, De Toni R, Palatini P. Albumin excretion rate increases during acute myocardial infarction and strongly predicts early mortality. Circulation 96,3338–3345 (1997).
   PubMed Web of Science ®Google Scholar
• ••Prevalence and predictive value ofmicroalbuminuria in acute myocardial infarction.
   Google Scholar
• Berton G, Cordiano R, Mbaso S, De Toni R, Mormino P, Palatini P Prognostic significance of hypertension and albuminuria for early mortality after acute myocardial infarction. J. Hypertens. 16, 525–530 (1998).
   PubMed Web of Science ®Google Scholar
• Smith PC, Gosling P, Sanghera K, Green MA, Paterson IS, Shearman CR Microproteinuria predicts the severity of systemic effects of reperfusion injury following infrarenal aortic aneurysm surgery. Ann. Vasc. Surg 8,1–5 (1994).
   PubMedGoogle Scholar
• Pallister I, Gosling P, Alpar K, Bradley S. Prediction of posttraumatic adult respiratory distress syndrome by albumin excretion rate eight hours after admission. j Trauma. 42,1056–1061 (1997).
   PubMedGoogle Scholar
• Gosling P, Sutcliffe AJ, Cooper MA, Jones AF Burn and trauma associated proteinuria: the role of lipid peroxidation, renin and myoglobin. Ann. Gun. Biochem. 25,53–59 (1988).
   Google Scholar
• Shearman CP, Gosling P, Walker KJ. Is low proteinuria an early predictor of severity of acute pancreatitis? j Gun. Pathol. 42, 1132–1135 (1989).
   Google Scholar
• Rome I. Microalbuminuria: an index of severity in childhood meningitis. Pediatr Infect. Dicj 12,584–588 (1993).
   Google Scholar
• Horton RC, Gosling P, Reeves CN, Payne M, Nagle RE. Microalbumin excretion in patients with positive exercise electrocardiogram tests. Eur Heart 15, 1353–1355 (1994).
   Google Scholar
• Shearman CP, Gosling P, Gwynn BR, Simms ME. Systemic effects associated with intermittent claudication. A model to study biochemical aspects of vascular disease? Eur j Vasc. Surg. 2,401–404 (1988).
   Google Scholar
• Pedersen LM, Milman N. Microalbuminuria in patients with lung cancer. Eur I Cancer34, 76–80 (1998).
   PubMed Web of Science ®Google Scholar
• Sawyer N, Wadsworth J, Wijnen M, Gabriel R. Prevalence, concentration and prognostic importance of proteinuria in patients with malignancies. Brit. Med. j 296,1295–1298 (1988).
   PubMedGoogle Scholar
• Viberti C. Prognostic significance of microalbuminuria. Am. j Hypertens. 7, 69S-72S (1994)
   Google Scholar
• •Summary of predictive value of microalbuminuria.
   Google Scholar
• Mogensen CE. Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas. Review. Diabetologia 42,263–285 (1999).
   PubMed Web of Science ®Google Scholar
• Mangrum A, Bakris GL. Predictors of renal and cardiovascular mortality in patients with non-insulin-dependent diabetes: A brief overview of microalbuminuria and insulin resistance. Review. j Diab. Comp. 11,352— 57 (1997).
   Google Scholar
• Gerstein HC, Mann JFE, Yi Q eta]. Albuminuria and risk of cardiovascular events, death and heart failure in diabetic and nondiabetic individuals. JAIVIA 286, 421–426 (2001).
   Google Scholar
• •• Prognostic significance of microalbuminuria in a large sample of both diabetics and nondiabetics.
   Google Scholar
• Roest M, Banga JD, Janssen WMT etal Excessive urinary albumin levels are associated with future cardiovascular mortality in postmenopausal women. Circulation. 103,3057–3061 (2001).
   PubMedGoogle Scholar
• •Increased albuminuria predicts future cardiovascular events and mortality.
   Google Scholar
• Hillege HL, Jannsen WM, Bak AA et al Microalbuminuria is common, also in a nondiabetic, nonhypertensive population and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J kit. Med. 249, 519–526 (2001).
   Google Scholar
• •Association between vascular risk-factors and microalbuminuria.
   Google Scholar
• Morrish NJ, Stevens LK, Fuller JH, Jarrett RJ, Keen H. Risk factors for macrovascular disease in diabetes mellitus: the London follow-up to the WHO Multinational Study of Vascular Disease in Diabetics. Diabetologia 34,590–594 (1991).
   PubMed Web of Science ®Google Scholar
• Sasaki A, Horiuchi A, Hasegawa K, Uehara M. Mortality from coronary heart disease and cerebrovascular disease and associated risk factors in diabetic patients in Osaka District, Japan. Diabetes Res. Gun. Pract 27, 77–83 (1995).
   Google Scholar
• Miettinen H, Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Looks° M. Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects. Stroke 27, 2033–2039 (1996).
   Google Scholar
• •Proteinuria as a risk-factor for stroke.
   Google Scholar
• Nakayama T, Date C, Yokoyama T, Yoshike N, Yamaguchi M, Tananka H. A 15.5-year follow-up study of stroke in a Japanese provincial city: The Shibata Study. Stroke 28, 45–52 (1997).
   Google Scholar
• Guerrero-Romero F, Rodriguez-Moran M. Proteinuria is an independent risk factor for ischemic stroke in non-insulin-dependent diabetes mellitus. Stroke 30, 1787–1791 (1999).
   Google Scholar
• Mykkänen L, Zaccaro DJ, O'Leary DH, Howard G, Robbins DC, Haffner SM. Microalbuminuria and carotid artery intima-media thickness in nondiabetic and NIDDM subjects. The insulin resistance atherosclerosis study (IRAS). Stroke 28, 1710–1716 (1997).
   Google Scholar
• •Association between microalbuminuria and atherosclerosis within the carotids.
   Google Scholar
• Slowik A, Turaj W, Strojny J, Szczudlik A. Microalbuminuria in nondiabetic patients with acute ischemic stroke: prevalence, clinical correlates and prognostic significance. Cerebrovasc. Dis. 14,15–21 (2002).
   PubMed Web of Science ®Google Scholar
• •• Prevalence and predictive value of microalbuminuria in patients with acute ischemic stroke.
   Google Scholar
• Beamer NB, Coull BM, Clark WM, Wynn M. Microalbuminuria in ischemic stroke. Arch. Neural 56, 699–702 (1999).
   PubMedGoogle Scholar
• Turaj W, Slowik A, Strojny J, Szczudlik A. Microalbuminuria and blood pressure in patients with acute ischemic stroke [in Polish]. Pal Merk. Lek. (2003) ( In Press).
   Google Scholar
• Szczudlik A, Turaj W Slowik A. Strojny J. Microalbuminuria and hyperthermia independently predict long-term mortality in acute ischemic stroke. Acta Neural Scam (2003) (In press).
   Google Scholar